338 related articles for article (PubMed ID: 11053528)
1. Iron deficiency alters dopamine transporter functioning in rat striatum.
Erikson KM; Jones BC; Beard JL
J Nutr; 2000 Nov; 130(11):2831-7. PubMed ID: 11053528
[TBL] [Abstract][Full Text] [Related]
2. Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum.
Kimmel HL; Carroll FI; Kuhar MJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):15-21. PubMed ID: 12490570
[TBL] [Abstract][Full Text] [Related]
3. Neonatal iron deficiency results in irreversible changes in dopamine function in rats.
Beard J; Erikson KM; Jones BC
J Nutr; 2003 Apr; 133(4):1174-9. PubMed ID: 12672939
[TBL] [Abstract][Full Text] [Related]
4. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine.
Thompson AC; Zapata A; Justice JB; Vaughan RA; Sharpe LG; Shippenberg TS
J Neurosci; 2000 Dec; 20(24):9333-40. PubMed ID: 11125013
[TBL] [Abstract][Full Text] [Related]
5. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
6. Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development.
Rothman RB; Mele A; Reid AA; Akunne H; Greig N; Thurkauf A; Rice KC; Pert A
FEBS Lett; 1989 Nov; 257(2):341-4. PubMed ID: 2583282
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices.
Hoffman AF; Lupica CR; Gerhardt GA
J Pharmacol Exp Ther; 1998 Nov; 287(2):487-96. PubMed ID: 9808671
[TBL] [Abstract][Full Text] [Related]
8. Drug interactions with the dopamine transporter in cryopreserved human caudate.
Eshleman AJ; Wolfrum K; Mash DC; Christensen K; Janowsky A
J Pharmacol Exp Ther; 2001 Feb; 296(2):442-9. PubMed ID: 11160629
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.
Claye LH; Akunne HC; Davis MD; DeMattos S; Soliman KF
Mol Neurobiol; 1995; 11(1-3):55-66. PubMed ID: 8561968
[TBL] [Abstract][Full Text] [Related]
11. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
Dutta AK; Xu C; Reith ME
J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474
[TBL] [Abstract][Full Text] [Related]
12. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.
Letchworth SR; Nader MA; Smith HR; Friedman DP; Porrino LJ
J Neurosci; 2001 Apr; 21(8):2799-807. PubMed ID: 11306632
[TBL] [Abstract][Full Text] [Related]
13. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC
J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383
[TBL] [Abstract][Full Text] [Related]
14. Prenatal cocaine alters dopamine transporter binding in postnatal day 10 rat striatum.
Collins LM; Meyer JS
Synapse; 1996 Aug; 23(4):335-43. PubMed ID: 8855519
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76.
Kimmel HL; Carroll FI; Kuhar MJ
Neuropharmacology; 2000 Feb; 39(4):578-85. PubMed ID: 10728879
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.
Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ
Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532
[TBL] [Abstract][Full Text] [Related]
17. Environmental enrichment enhances sensitization to GBR 12935-induced activity and decreases dopamine transporter function in the medial prefrontal cortex.
Zhu J; Green T; Bardo MT; Dwoskin LP
Behav Brain Res; 2004 Jan; 148(1-2):107-17. PubMed ID: 14684252
[TBL] [Abstract][Full Text] [Related]
18. Medial dorsal striatum is more sensitive than lateral dorsal striatum to cocaine inhibition of exogenous dopamine clearance: relation to [3H]mazindol binding, but not striosome/matrix.
Cline EJ; Adams CE; Larson GA; Gerhardt GA; Zahniser NR
Exp Neurol; 1995 Jul; 134(1):135-49. PubMed ID: 7672034
[TBL] [Abstract][Full Text] [Related]
19. A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters?
Sharif NA; Nunes JL; Kalfayan V; McClelland DL; Rosenkranz RP; Eglen RM; Whiting RL
Neurochem Int; 1992 Jul; 21(1):69-73. PubMed ID: 1303143
[TBL] [Abstract][Full Text] [Related]
20. Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter.
Rothman RB; Grieg N; Kim A; De Costa BR; Rice KC; Carroll FI; Pert A
Pharmacol Biochem Behav; 1992 Dec; 43(4):1135-42. PubMed ID: 1475296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
